ClinicalTrials.Veeva

Menu

Evaluation of the Evolution of Pregnancies in the First Trimester Following MAR Management During a COVD-19 Pandemic Period (AMPCOVID-19)

U

University Hospital, Strasbourg, France

Status

Completed

Conditions

Covid-19

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Because of the physiological changes inherent in pregnancy, pregnant women with lower respiratory tract infections often have more worrisome outcomes compared to non-pregnant individuals, including a higher rate of hospital and intensive care unit admissions.

Enrollment

700 patients

Sex

Female

Ages

18 to 43 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient included in a Medically Assisted Procreation (MAR) protocol aged between 18 and 43 years of age
  • Patient who has already signed a consent to management

Exclusion criteria

  • Patient who expressed opposition to participating in the study

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems